Sun Pharmaceutical Industries Ltd.

The company's total revenue for the quarter ended June 2024 saw a slight change in the total revenue, having registered a total revenue of Rs. 44980.70 millions.The Company to register a -37.52%  fall in the net profit for the quarter ended June 2024.The company reported a degrowth in operating Profit to 8438.10 millions from 11123.00 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202406	202306	% Var	202406	202306	% Var	202403	202303	% Var
Sales	44980.70	44660.70	0.72	44980.70	44660.70	0.72	202751.70	208121.40	-2.58
Other Income	827.40	1635.40	-49.41	827.40	1635.40	-49.41	5534.80	3292.90	68.08
PBIDT	8438.10	11123.00	-24.14	8438.10	11123.00	-24.14	60533.70	67518.90	-10.35
Interest	2160.80	1579.40	36.81	2160.80	1579.40	36.81	7840.80	4721.80	66.06
PBDT	6277.30	8051.50	-22.04	6277.30	8051.50	-22.04	50502.70	33419.20	51.12
Depreciation	3698.10	4152.70	-10.95	3698.10	4152.70	-10.95	16006.20	16008.70	-0.02
PBT	2579.20	3898.80	-33.85	2579.20	3898.80	-33.85	34496.50	17410.50	98.14
TAX	201.00	92.40	117.53	201.00	92.40	117.53	5914.70	503.30	1075.18
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	2378.20	3806.40	-37.52	2378.20	3806.40	-37.52	28581.80	16907.20	69.05
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	18.76	24.91	-24.68	18.76	24.91	-24.68	29.86	32.44	-7.97